Gizem Babuccu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gizem Babuccu has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Fusun Can
Koç University İşbank Center for Infectious Diseases (KUISCID)
3 shared publications - Ozlem Dogan
Department of Medical Microbiology, Koç University School of Medicine, 34450 Istanbul, Turkey
2 shared publications Ş Ahin
Environmental Engineering, Istanbul University-Cerrahpasa, Istanbul, Turkey
1 shared publication- Ahmet Altin
Department of Environmental Engineering, Bulent Ecevit University, Zonguldak, Turkey
1 shared publication - Alpay Ari
Department of Infectious Diseases and Clinical Microbiology, Izmir Faculty of Medicine, University of Health Sciences, İzmir
1 shared publication - Arslan Saral
Department of Environmental Engineering Faculty of Civil Engineering Yildiz Technical University 34220 İstanbul Türkiye
1 shared publication
Latest Publications
- Open Access
- 20 November 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (11) , 1172
Machine Learning-Identified Potent Antimicrobial Peptides Against Multidrug-Resistant Bacteria and Skin Infections
Background: The escalating global crisis of antibiotic resistance necessitates the discovery of novel antimicrobial agents. Antimicrobial peptides (AMPs) represent a promising alternative to combat multidrug-resistant (MDR) pathogens. Because traditional AMP discovery is labour-intensive and costly, machine learning (ML) is applied to identify AMPs effective against MDR bacteria and skin infections. Methods: The ML-based CalcAMP model predicts the antimicrobial activity of 16,384 unique 14-amino-acid peptide sequences, resulting in a novel Guided Designed Smart antimicrobial Therapeutic (GDST) peptide catalogue. Parent sequences and retro-inverso (RI) variants of two prime GDST peptides undergo extensive testing against MDR bacteria and in skin infection models. Results: GDST-038 and GDST-045, along with their RI variants, show potent antimicrobial activity against Acinetobacter baumannii and Staphylococcus aureus, rapidly depolarizing the cytoplasmic membrane, exhibiting broad-spectrum bactericidal effects against ESKAPE pathogens, and causing minimal haemolysis. RI variants display superior A. baumannii biofilm killing compared to parent sequences, while all GDST peptides achieve >3-log reductions in S. aureus biofilm CFU within 24 h. Potent efficacy is observed in a 3D human skin epidermal infection model, with elimination of S. aureus at ≥15 μM. No resistance develops after 22 passages. Conclusions: ML-driven screening enables rapid identification of two novel candidate AMPs, highlighting the therapeutic potential of GDST peptides for MDR bacterial infections.
- 20 November 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (11) , 1172
Open AccessMachine Learning-Identified Potent Antimicrobial Peptides Against Multidrug-Resistant Bacteria and Skin Infections
Background: The escalating global crisis of antibiotic resistance necessitates the discovery of novel antimicrobial agents. Antimicrobial peptides (AMPs) represent a promising alternative to combat multidrug-resistant (MDR) pathogens. Because traditional AMP discovery is labour-intensive and costly, machine learning (ML) is applied to identify AMPs effective against MDR bacteria and skin infections. Methods: The ML-based CalcAMP model predicts the antimicrobial activity of 16,384 unique 14-amino-acid peptide sequences, resulting in a novel Guided Designed Smart antimicrobial Therapeutic (GDST) peptide catalogue. Parent sequences and retro-inverso (RI) variants of two prime GDST peptides undergo extensive testing against MDR bacteria and in skin infection models. Results: GDST-038 and GDST-045, along with their RI variants, show potent antimicrobial activity against Acinetobacter baumannii and Staphylococcus aureus, rapidly depolarizing the cytoplasmic membrane, exhibiting broad-spectrum bactericidal effects against ESKAPE pathogens, and causing minimal haemolysis. RI variants display superior A. baumannii biofilm killing compared to parent sequences, while all GDST peptides achieve >3-log reductions in S. aureus biofilm CFU within 24 h. Potent efficacy is observed in a 3D human skin epidermal infection model, with elimination of S. aureus at ≥15 μM. No resistance develops after 22 passages. Conclusions: ML-driven screening enables rapid identification of two novel candidate AMPs, highlighting the therapeutic potential of GDST peptides for MDR bacterial infections.
Early Human Neutrophil Response to Different Morphotypes of Candida albicans Compared to Bacterial Pathogens
Neutrophils are among the first immune cells recruited during the critical early phase of infection; yet their reaction to Candida albicans morphotypes is not fully defined. Here, we aimed to investigate early neutrophil responses to C. albicans morphotypes compared to bacteria. Freshly isolated human neutrophils were incubated with heat‐killed C. albicans, live C. albicans, Escherichia coli, and Staphylococcus aureus as bacterial comparisons for 30 min, 1 h, and 4 h. Afterward, neutrophil activation was assessed via gene expression of neutrophil elastase (ELANE) and myeloperoxidase (MPO), CD66b/CD11b surface marker expression, microbicidal activity, and cytokine release, including IL‐22, IL‐17A, IL‐1ɑ, IL‐1β, TNF‐ɑ, and IL‐6. Neutrophil response pathways were significantly more activated by hyphal C. albicans than HK C. albicans, E.coli, and S. aureus, including the highest MPO and ELANE expression within the first 4 h, compared to heat‐killed C. albicans and bacteria. CD66b expression significantly upregulated at 1 h in response to hyphal C. albicans. Neutrophils exhibited a 68% candidacidal effect at 1 h. IL‐22 peaked at 1 h and remained elevated; heat‐killed C. albicans induced IL‐22 and IL‐17A at 4 h. Neutrophils show stronger early responses against C. albicans morphotypes compared to E. coli and S. aureus, particularly within 1 h.
Early Human Neutrophil Response to Different Morphotypes of Candida albicans Compared to Bacterial Pathogens
Neutrophils are among the first immune cells recruited during the critical early phase of infection; yet their reaction to Candida albicans morphotypes is not fully defined. Here, we aimed to investigate early neutrophil responses to C. albicans morphotypes compared to bacteria. Freshly isolated human neutrophils were incubated with heat‐killed C. albicans, live C. albicans, Escherichia coli, and Staphylococcus aureus as bacterial comparisons for 30 min, 1 h, and 4 h. Afterward, neutrophil activation was assessed via gene expression of neutrophil elastase (ELANE) and myeloperoxidase (MPO), CD66b/CD11b surface marker expression, microbicidal activity, and cytokine release, including IL‐22, IL‐17A, IL‐1ɑ, IL‐1β, TNF‐ɑ, and IL‐6. Neutrophil response pathways were significantly more activated by hyphal C. albicans than HK C. albicans, E.coli, and S. aureus, including the highest MPO and ELANE expression within the first 4 h, compared to heat‐killed C. albicans and bacteria. CD66b expression significantly upregulated at 1 h in response to hyphal C. albicans. Neutrophils exhibited a 68% candidacidal effect at 1 h. IL‐22 peaked at 1 h and remained elevated; heat‐killed C. albicans induced IL‐22 and IL‐17A at 4 h. Neutrophils show stronger early responses against C. albicans morphotypes compared to E. coli and S. aureus, particularly within 1 h.
- Open Access
- 19 December 2024
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (4) , 258-267
Predictive Role and Clinical Value of Serum Cytokines in COVID-19
COVID-19 is caused by SARS-CoV-2 from the Coronaviridae family, Orthocoronaviridae sub family, Betacoronavirus genus, and Sarbecovirus subfamily (1). Cytokines and chemokines have been essential in the immune response against coronaviruses (2). First reports investigating clinical features of COVID-19 showed that serum levels of interleukin (IL)-2, IL-7, IL-10, granulocyte colony-stimulating factor (GSCF), IP10 (CXCL10),
- 19 December 2024
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (4) , 258-267
Open AccessPredictive Role and Clinical Value of Serum Cytokines in COVID-19
COVID-19 is caused by SARS-CoV-2 from the Coronaviridae family, Orthocoronaviridae sub family, Betacoronavirus genus, and Sarbecovirus subfamily (1). Cytokines and chemokines have been essential in the immune response against coronaviruses (2). First reports investigating clinical features of COVID-19 showed that serum levels of interleukin (IL)-2, IL-7, IL-10, granulocyte colony-stimulating factor (GSCF), IP10 (CXCL10),
- 30 December 2021
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 3 (3) , 158-163
Comparison of Crystal Violet Staining Assay and XTT Methods in the Evaluation of Biofilm Formation in Candida parapsilosis Candidemia Isolates
Objective: Biofilm formation is one of the most important virulence factors of Candida species which leads to permanent infection foci by adhering to foreign materials and which are difficult to treat. Candida parapsilosis, which is one of the most common causes of candidemia in our country, is frequently isolated as a causative agent in catheter-related infections. The most commonly used methods for evaluating the biofilm formation of Candida species are measuring cell viability with XTT (2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) arbonyl]-2H-tetrazolium hydroxide) and evaluating the total biofilm mass with crystal violet (CV). The aim of this study is to evaluate the biofilm formation ability of C. parapsilosis candidemia isolates by XTT and (CV) methods and compare these methods with each other. Materials and Methods: C. parapsilosis isolates sent from various hospitals between 2015 and 2019 were included in the study retrospectively, and the species-level identification was performed using the matrix- assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) The biofilm formation of the isolates was compared based on the optical density (OD) values obtained by crystal violet and XTT methods. The biofilm formation of the isolates was evaluated by categorizing them into low, medium and high biofilm groups as ± 20% according to the median value of all strains. Results: Totally, 79 C. parapsilosis candidemia isolates were included in this study and categorical compatibility between CV and XTT methods in low, medium and high biofilm groups was found as 69.6%, 60.6% and 73.9%, respectively. The OD values of the XTT method in the high biofilm group were found statistically significantly higher when compared with the values from the CV method. Conclusion: The compatibility of XTT and crystal violet methods in terms of biofilm measurement in C. parapsilosis isolates was considered acceptable, and no major variations were detected between the categories. According to these results, when evaluating the biofilm levels of C. parapsilosis isolates, high OD values obtained by the XTT method should be confirmed with the CV method. Keywords: C. parapsilosis, candidemia, biofilm
- 30 December 2021
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 3 (3) , 158-163
Comparison of Crystal Violet Staining Assay and XTT Methods in the Evaluation of Biofilm Formation in Candida parapsilosis Candidemia Isolates
Objective: Biofilm formation is one of the most important virulence factors of Candida species which leads to permanent infection foci by adhering to foreign materials and which are difficult to treat. Candida parapsilosis, which is one of the most common causes of candidemia in our country, is frequently isolated as a causative agent in catheter-related infections. The most commonly used methods for evaluating the biofilm formation of Candida species are measuring cell viability with XTT (2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) arbonyl]-2H-tetrazolium hydroxide) and evaluating the total biofilm mass with crystal violet (CV). The aim of this study is to evaluate the biofilm formation ability of C. parapsilosis candidemia isolates by XTT and (CV) methods and compare these methods with each other. Materials and Methods: C. parapsilosis isolates sent from various hospitals between 2015 and 2019 were included in the study retrospectively, and the species-level identification was performed using the matrix- assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) The biofilm formation of the isolates was compared based on the optical density (OD) values obtained by crystal violet and XTT methods. The biofilm formation of the isolates was evaluated by categorizing them into low, medium and high biofilm groups as ± 20% according to the median value of all strains. Results: Totally, 79 C. parapsilosis candidemia isolates were included in this study and categorical compatibility between CV and XTT methods in low, medium and high biofilm groups was found as 69.6%, 60.6% and 73.9%, respectively. The OD values of the XTT method in the high biofilm group were found statistically significantly higher when compared with the values from the CV method. Conclusion: The compatibility of XTT and crystal violet methods in terms of biofilm measurement in C. parapsilosis isolates was considered acceptable, and no major variations were detected between the categories. According to these results, when evaluating the biofilm levels of C. parapsilosis isolates, high OD values obtained by the XTT method should be confirmed with the CV method. Keywords: C. parapsilosis, candidemia, biofilm